SCHEMBL6479592

SCHEMBL6479592

COCCOCOc1c(C(=O)OC)ccc2c(C)ccnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
CCR1 P32246 2/20 0.39
CCR5 P51681 2/20 0.39
CCR8 P51685 2/20 0.39
ALDH1A1 P00352 1/20 0.38
PSMD14 O00487 1/20 0.38
SLC40A1 Q9NP59 2/20 0.33
GRM4 Q14833 2/20 0.33
RARG P13631 1/20 0.33
F2 P00734 1/20 0.33
ELANE P08246 1/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
EGLN1 Q9GZT9 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7867705 0.78 MAPT (0.39) KDM4EALDH1A1RARGF2ELANE
SCHEMBL6479897 0.76 KDM4E (0.52) KDM4ECCR1CCR5CCR8PSMD14
SCHEMBL13943230 0.76 CCR1 (0.52) KDM4ECCR1CCR5CCR8ALDH1A1
SCHEMBL6043188 0.73 HDAC3 (0.59) KDM4EALDH1A1HDAC1HDAC8HDAC6
SCHEMBL1496808 0.70 ALDH1A1 (0.50) KDM4EALDH1A1GRM4HDAC1HDAC8
SCHEMBL6492605 0.69 CNR1 (0.36) ALDH1A1F2ELANE
SCHEMBL6479505 0.68 CCR1 (0.41) KDM4ECCR1CCR8ALDH1A1PSMD14
SCHEMBL13010894 0.68 ALDH1A1 (0.45) KDM4EALDH1A1L3MBTL1
SCHEMBL21878477 0.67 KDM4E (0.64) KDM4ECCR1CCR8ALDH1A1PSMD14
SCHEMBL12329804 0.67 KDM4E (0.38) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors ZHUANG LINGHANG (US) 2005-01-13 US disclosed
EP-1333831-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-08-13 EP disclosed
WO-2002036734-A2 AZA-AND POLYAZA-NAPHTHALENYL KETONES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010048-A1 Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors POLI, CYP51A1, DUT KDM4E 140/4885CCR1 2558/4885CCR5 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.